TerrAscend (TSNDF) Current Assets (2021 - 2026)
TerrAscend's (TSNDF) quarterly Current Assets came in at $102.4 million in Q1 2026, up 1.23% year-on-year from $101.2 million in Q1 2025, and down 6.96% on a QoQ basis from $110.1 million in Q4 2025.
TerrAscend (TSNDF) Current Assets (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Current Assets data on file, last reported at $102.4 million in Q1 2026.
- On a quarterly basis, Current Assets rose 1.23% year-over-year to $102.4 million in Q1 2026; TTM through Mar 2026 was $102.4 million, a 1.23% increase from a year earlier, with the FY2025 full-year figure at $110.1 million, down 37.75% from the prior year.
- Current Assets for Q1 2026 stood at $102.4 million, down from $110.1 million in the prior quarter.
- Over the last five years, Current Assets for TSNDF reached as high as $187.1 million in Q1 2022 and fell as low as $97.7 million in Q1 2024.
- Historically, Current Assets has averaged $120.1 million across 5 years, with a median of $110.1 million in 2025.
- Across the five-year window, Current Assets tumbled 39.2% in 2023 and jumped 71.92% in 2024, its largest moves.
- Year by year, Current Assets stood at $122.0 million in 2022, then slipped by 15.66% to $102.9 million in 2023, then surged by 71.92% to $176.9 million in 2024, then tumbled by 37.75% to $110.1 million in 2025, then declined by 6.96% to $102.4 million in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $102.4 million in Q1 2026, $110.1 million in Q4 2025, and $119.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | 102.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 102.44 Mn |
| Dec 31, 2025 | 110.11 Mn |
| Sep 30, 2025 | 119.37 Mn |
| Jun 30, 2025 | 133.08 Mn |
| Mar 31, 2025 | 101.20 Mn |
| Dec 31, 2024 | 176.89 Mn |
| Sep 30, 2024 | 105.71 Mn |
| Jun 30, 2024 | 104.81 Mn |
| Mar 31, 2024 | 97.66 Mn |
| Dec 31, 2023 | 102.89 Mn |
| Sep 30, 2023 | 107.21 Mn |
| Jun 30, 2023 | 106.63 Mn |
| Mar 31, 2023 | 113.78 Mn |
| Dec 31, 2022 | 121.99 Mn |
| Sep 30, 2022 | 113.40 Mn |
| Jun 30, 2022 | 137.32 Mn |
| Mar 31, 2022 | 187.14 Mn |
| Dec 31, 2021 | 172.49 Mn |